The Economic Values and Roles of Contract Manufacturing Organization (CMO) and Contact Development Manufacturing Organization (CDMO) in the Taiwan Pharmaceutical Industry

• Main Authors: Yi Chin Wu, 吳宜靜
• Other Authors: Y. J. Meir
• Format: Others
• Language: zh-TW
• Published: 2017
• Online Access: http://ndltd.ncl.edu.tw/handle/re2usy

碩士 === 長庚大學 === 生物科技產業碩士學位學程 === 105 === Pharmaceutical industry is an important sub-industry in the field of biotechnology in Taiwan, and Taiwan plays the manufacturing role as contract manufacturing organization (CMO) and contact development manufacturing organization (CDMO) in international pharmacy field. Therefore, the aim of this thesis is to study CMO’s and CDMO’s value and roles in Taiwan pharmaceutical industry. By using secondary analysis and in-depth interview with domestic manufacturers, the present study tried to analyze the business model and discover the industrial value of Taiwan pharmaceutical industry. In this thesis, comparing the business model of each company will be operated by case study and the sub-data method. There are three main goals in this study: 1. To analyze the business models in foreign pharmaceutical manufacturers. 2. To use SWOT analysis for identifying the role of Taiwan's pharmaceutical industry. 3. To take UBIP as an example, to find niche points in Taiwan's CMO and CDMO companies. According to the information we analyzed, the progress of pharmaceutical industry is under the great concern from our government, the policies includes taxes reduce, building biomedical industry park, labor training and technical issues. Due to different marketing size and smaller manufactories in Taiwan, the suppliers need to set up their niche points with its own advantage, and may shorten development duration of the drug with these supports. These CMO and CDMO companies also get resource by strengthening the specification, patent protection, upgrading of facilities, and knowing the trend of domestic market to get more possibilities obtaining more profit.